Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Neovascular Age-elated Macular Degeneration (Wet AMD)
View Full LandscapeTarget Indication
Neovascular Age-elated Macular Degeneration (Wet AMD)
Clinical Trial
NCT01535950Last updated: 4/9/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Multiple Sclerosis
Solid Tumors
Influenza
Chronic Obstructive Pulmonary Disease
Swine-Origin Influenza A H1N1 Virus